DRUG

Bright Minds Biosciences
DRUG

Overview Fund Activity

9 hedge funds and large institutions have $2.93M invested in Bright Minds Biosciences in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
9
Holders Change
+9
Holders Change %
–
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
O
1
OrbiMed
New York
$2.13M
2
IC
2
Ikarian Capital
Texas
$317K
3
AI
3
AdvisorShares Investments
Maryland
$304K
4
QFA
4
Quattro Financial Advisors
Texas
$67K
5
CCA
5
Checchi Capital Advisers
California
$45K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
O
1
OrbiMed
New York
$2.13M 660,600 +660,600 New
IC
2
Ikarian Capital
Texas
$317K 100,000 +100,000 New
AI
3
AdvisorShares Investments
Maryland
$304K 95,942 +95,942 New
QFA
4
Quattro Financial Advisors
Texas
$67K 21,150 +21,150 New
CCA
5
Checchi Capital Advisers
California
$45K 14,138 +14,138 New
BFM
6
Boothbay Fund Management
New York
$35K 11,040 +11,040 New
BlackRock
7
BlackRock
New York
$20K 6,169 +6,169 New
UBS Group
8
UBS Group
Switzerland
$5K 1,558 +1,558 New
APC
9
Aspire Private Capital
North Carolina
$2K 500 +500 New
CFGS
10
Concourse Financial Group Securities
Alabama
– – – –